Skip to content
Pfizer’s ABRYSVO vaccine for respiratory syncytial virus (RSV) received U.S. Food and Drug Administration (FDA) approval for use in adults over age 60 on […]
FDA approves Pfizer’s RSV vaccine for adults over age 60 Read More »
On May 23, the House Committee on Oversight and Accountability sought to answer this question: are PBMs (pharmacy benefit managers) working in the interest
Are PBMs working in the interest of health care – or themselves? Read More »
Pharmacy benefit managers (PBMs) and hospitals using the 340B program were in the crosshairs on May 17 as the House Energy & Commerce Health
E&C Health Subcommittee advances bills to bring transparency to PBMs and 340B Read More »
U.S. Senators have been busy this week understanding and pushing forward PBM reform. On May 10, the Senate Health, Education, Labor, and Pensions (HELP) Committee
Senate HELP Committee advances PBM reform Read More »
Every year, Mother’s Day kicks off National Women’s Health Week. So what are a few simple things that women can do to stay healthy?
3 steps to better health for National Women’s Health Week Read More »
“What scientists are telling us is that there is a reasonable chance that—God forbid—a pandemic is deadly as COVID-19 could occur in 10 years,”
What they said at the Senate HELP hearing on PAHPA reauthorization Read More »
Drug makers have been racing at a breakneck pace to develop respiratory syncytial virus (RSV) vaccines this year. On May 3, the U.S. Food
FDA approves first RSV vaccine Read More »
The Senate Health, Education, Labor, and Pension (HELP) Committee on May 2 discussed Senate Bill 1339, “The Pharmacy Benefit Manager Reform Act,” and three
Vote on Pharmacy Benefit Manager Reform Act delayed until May 11 Read More »
Every April, the FDA observes National Minority Health Month “to raise awareness of the importance of improving the health of racial and ethnic minority
National Minority Health Month: in conversation with Dr. Reed Tuckson and Reggie Ware Read More »
Pharmacy benefit managers (or PBMs) are in the news again as federal regulators and politicians work to shed light on the questionable and purposefully
The Senate Finance Committee trains its sights on PBMs Read More »
